LIONVILLE, Pa.—Donald E. Morel Jr. has been appointed CEO of West Pharmaceutical Services Inc.
The executive has been president and chief operating officer since May 2001, and will retain the president´s title. He succeeds William G. Little, who will continue to serve as chairman until he retires in the spring of 2003.
Morel joined West in 1992 as vice president of scientific services, in charge of global research and development. Since then he has held a variety of key jobs, including group president for the core components business, and president of drug delivery systems.